Equity Rights Offering $55M with $30M backstop
Company: Core Scientific
The claim, verbatim
A $55 million best-efforts equity rights offering for existing equity at a 30% discount to plan equity value. It has a $30 million backstop, with best efforts to secure an additional $25 million of backstop.
Source (primary)
core-scientific 8-K exhibit (d524676dex992.htm) (SEC EDGAR (8-K Ex), press_release)
View cached copy (2026-11-18)Live source ↗
Quote: “$30 million backstop with best efforts to secure an incremental $25 million of backstop, for a total of $55 million”
How we checked this
Checked on November 20, 2026. The cited source supports every part of this claim.
The term sheet gives existing equity the right to invest $55 million via the rights offering. It describes the 30% discount and the $30 million backstop with best efforts to secure another $25 million.
Confirmed in the source:
- The equity rights offering is $55 million on a best-efforts basis
- The rights offering is offered to existing equity
- The rights offering is priced at a 30% discount to plan equity value
- The rights offering has a $30 million backstop
- There are best efforts to secure an incremental $25 million of backstop
What we did: Read our cached copy of SEC EDGAR (8-K Ex) (https://www.sec.gov/Archives/edgar/data/1839341/000119312523266221/d524676dex992.htm) in full (18,293 characters, retrieved November 18, 2026) and checked each assertion in the claim against it.
Additional evidence
confirms core-scientific 8-K exhibit (d524676dex992.htm)
Quote: “$30 million backstop with best efforts to secure an incremental $25 million of backstop, for a total of $55 million”